SCHEMBL24690138

SCHEMBL24690138

CCC(=N)Nc1ccc2[nH]ncc2c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 6/20 0.62
▸ ROCK1 Q13464 6/20 0.62
▸ NPC1 O15118 6/20 0.54
▸ RAB9A P51151 5/20 0.54
▸ MEN1 O00255 3/20 0.54
▸ KMT2A Q03164 3/20 0.54
▸ JAK2 O60674 2/20 0.54
▸ JAK1 P23458 1/20 0.54
▸ L3MBTL1 Q9Y468 1/20 0.54
▸ DHODH Q02127 1/20 0.52
▸ PRKD3 O94806 1/20 0.51
▸ MAP4K4 O95819 1/20 0.51
▸ RPS6KB1 P23443 1/20 0.51
▸ CLK2 P49760 1/20 0.51
▸ DYRK1A Q13627 1/20 0.51
▸ PRKG1 Q13976 1/20 0.51
▸ PRKD2 Q9BZL6 1/20 0.51
▸ CLK4 Q9HAZ1 1/20 0.51
▸ SGK2 Q9HBY8 1/20 0.51
▸ STK17A Q9UEE5 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15934021 0.83 ROCK2 (0.53) ROCK2ROCK1NPC1RAB9AMEN1
SCHEMBL17776529 0.82 ROCK2 (0.71) ROCK2ROCK1NPC1RAB9AMEN1
SCHEMBL20611859 0.81 ROCK2 (0.64) ROCK2ROCK1NPC1RAB9AMEN1
SCHEMBL10310329 0.80 ROCK2 (0.63) ROCK2ROCK1NPC1RAB9AMEN1
SCHEMBL2572294 0.79 ROCK2 (0.66) ROCK2ROCK1NPC1RAB9AMEN1
SCHEMBL23075124 0.77 CNR1 (0.69) ROCK2ROCK1NPC1RAB9AMEN1
SCHEMBL2565558 0.77 ROCK2 (1.00) ROCK2ROCK1NPC1RAB9AMEN1
SCHEMBL12257075 0.76 JAK2 (0.60) ROCK2ROCK1NPC1RAB9AMEN1
SCHEMBL21341425 0.76 ROCK2 (0.58) ROCK2ROCK1NPC1RAB9AMEN1
SCHEMBL4501257 0.76 ROCK2 (0.66) ROCK2ROCK1NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3421465-B1 RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AS WELL AS PREPARATION METHOD AND USE THEREOF BEIJING TIDE PHARMACEUTICAL CO LTD (CN) 2022-10-26 — — EP disclosed
Send feedback